GHK-Cu and BPC-157 show up together constantly in peptide research discussions, often lumped into the same general "recovery" category. They're not structurally related, and the research literature behind each points at fairly distinct mechanisms. Here's a side-by-side comparison.
At a glance
| GHK-Cu | BPC-157 | |
|---|---|---|
| Structure | Tripeptide (Gly-His-Lys) bound to a copper(II) ion | Pentadecapeptide (15 amino acids) |
| Origin | Naturally occurring in human plasma; first isolated in the 1970s | Synthetic peptide based on a partial sequence identified in human gastric juice |
| Molecular weight | ~401.9 g/mol | ~1,419.5 g/mol |
| Primary research focus | Collagen/extracellular matrix signaling, wound healing, antioxidant activity | Tendon, ligament, and gastrointestinal tissue repair pathways in preclinical models |
| Common research pairing | Often studied alongside TB-500 and BPC-157 in combined tissue-repair models (see our GLOW-80 blend) | Often studied alongside TB-500 and GHK-Cu for the same reason |
GHK-Cu's research angle
GHK-Cu's research interest centers on its role as a signaling molecule connected to collagen and elastin synthesis, extracellular matrix remodeling, and antioxidant activity. Its natural decline in plasma concentration with age has made it a recurring reference point in tissue-aging research specifically. Read the full GHK-Cu research overview.
BPC-157's research angle
BPC-157's research focus centers on preclinical models of tendon, ligament, and gastrointestinal tissue repair — its origin in gastric juice has made gut-lining and vascular repair pathways a particular focus of the literature around it, alongside broader musculoskeletal recovery research.
Why they're often studied together
Because they're understood to act through different mechanisms — GHK-Cu through matrix/collagen signaling, BPC-157 through a separate tissue-repair pathway — some researchers examine them alongside each other (often with TB-500 added as a third component) to study how these pathways interact in a combined model, rather than in isolation. This is the logic behind pre-blended research products like our GLOW-80, which combines GHK-Cu, BPC-157, TB-500, and KPV in one vial specifically to support that kind of multi-pathway study.